UBS Group’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,445
| Closed | -$621 | – | 8977 |
|
|
2023
Q3 | $621 | Buy |
1,445
+137
| +10% | +$59 | ﹤0.01% | 7224 |
|
|
2023
Q2 | $1.66K | Hold |
1,308
| – | – | ﹤0.01% | 6794 |
|
|
2023
Q1 | $1.83K | Sell |
1,308
-435
| -25% | -$609 | ﹤0.01% | 7537 |
|
|
2022
Q4 | $6.54K | Buy |
1,743
+435
| +33% | +$1.63K | ﹤0.01% | 7828 |
|
|
2022
Q3 | $6K | Hold |
1,308
| – | – | ﹤0.01% | 8009 |
|
|
2022
Q2 | $12K | Sell |
1,308
-650
| -33% | -$5.96K | ﹤0.01% | 6674 |
|
|
2022
Q1 | $13K | Sell |
1,958
-13,709
| -88% | -$91K | ﹤0.01% | 7049 |
|
|
2021
Q4 | $135K | Buy |
15,667
+9,136
| +140% | +$78.7K | ﹤0.01% | 4966 |
|
|
2021
Q3 | $80K | Buy |
6,531
+5,361
| +458% | +$65.7K | ﹤0.01% | 4910 |
|
|
2021
Q2 | $10K | Buy |
+1,170
| New | +$10K | ﹤0.01% | 6970 |
|